CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1
Biochemical and Biophysical Research Communications · 2024-11 · 733 · 150729
DOI: 10.1016/j.bbrc.2024.150729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-11. Verfasst von Yoshitaka Aoki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi, Tokyo, 204-8588, Japan. Electronic add…. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Myotonic Dystrophy, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Myotonic dystrophy type 1 (DM1) is caused by the expansion of a non-coding CTG repeat in DMPK. CUG-repeat-containing transcripts sequester the splicing regulator MBNL1 into nuclear RNA foci, causing aberrant splicing of many genes. Although the mislocalization of MBNL1 represents a causal event in DM1 pathogenesis, the effect of CUG repeat RNA on the protein level of MBNL1 remains unclear. Using a DM1 model cell line, we found that CUG repeat RNA caused a significant decrease in the protein, but not mRNA levels, of MBNL1. As CUG repeats did not decrease MBNL1 translation, we investigated protein degradation pathways. Although autophagy-related reagents induced little change, proteasome inhibitors partially recovered MBNL1 protein expression levels under conditions of CUG repeat expression and induced a slight, but significant, reversal of splicing dysregulation. MBNL1 was detected in the polyubiquitinated protein fraction, but MBNL1 polyubiquitination was not detected. Moreover, inhibition of the ubiquitin-activating enzyme E1 did not increase MBNL1 levels, suggesting that MBNL1 is a substrate of polyubiquitin-independent proteasomal degradation. These results suggest that CUG-repeat-induced proteasomal degradation partially contributes to the functional decline of MBNL1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi, Tokyo, 204-8588, Japan. Electronic address: d246901@std.my-pharm.ac.jp.
- Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi, Tokyo, 204-8588, Japan. Electronic address: m-yana@my-pharm.ac.jp.
- Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi, Tokyo, 204-8588, Japan. Electronic address: m236210@std.my-pharm.ac.jp.
- Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi, Tokyo, 204-8588, Japan. Electronic address: m196221@alm.my-pharm.ac.jp.
- Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose-shi, Tokyo, 204-8588, Japan. Electronic address: kino@my-pharm.ac.jp.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
Zitieren
APA
Aoki, Y., Yanaizu, M., Ohki, A., Nishimiya, K., & Kino, Y. (2024). CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1. Biochemical and Biophysical Research Communications, 733, 150729. https://doi.org/10.1016/j.bbrc.2024.150729
Vancouver
Aoki Y, Yanaizu M, Ohki A, Nishimiya K, Kino Y. CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1. Biochemical and Biophysical Research Communications. 2024;733:150729. doi:10.1016/j.bbrc.2024.150729
BibTeX
@article{Aoki2024,
author = {Aoki, Yoshitaka and Yanaizu, Motoaki and Ohki, Ai and Nishimiya, Kai and Kino, Yoshihiro},
title = {CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {733},
pages = {150729},
doi = {10.1016/j.bbrc.2024.150729}
}
EUVIMED